Get the Stockscreener App
0.1953
2.79%
+0.0053
After Hours:
.1999
0.0046
+2.36%
Why is Galera Therapeutics Inc (GRTX) Stock down?
We've noticed a 5.14% decline in Galera Therapeutics Inc (GRTX) stock during the 2024-05-10 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
31 Oct, 2023:
Galera Therapeutics Stock (GRTX) dropped by 54.02% from $0.2112 to $0.0971 in the trading on Tuesday October 31, 2023. The reason why GRTX stock down today is due to warns of potential shutdown as it halts clinical trials. The company will be forced to discontinue operations if it fails to find strategic alternatives. The warnings come after an FDA Type A meeting in September, during which the regulator requested an additional Phase 3 trial to review its lead asset, avasopasem manganese, targeted at radiotherapy-driven severe oral mucositis. Meanwhile, the company has decided to halt two mid-stage trials, as GRECO-2 trial did not pass futility analysis.
4.27%
2.59%
Cap:
|
Volume (24h):